Ziva DRA supports pharmaceutical, medical device, diagnostic and healthcare companies with regulatory dossier planning, document-gap assessment, content organization, market-specific adaptation and submission-readiness support.
Regulatory dossier preparation brings together product, manufacturer, quality, technical, safety, clinical and administrative information into a structured file aligned with the applicable registration pathway.
Ziva DRA helps clients evaluate available documentation, identify gaps, organize regulatory content and coordinate the supporting workstreams required to move the dossier toward submission readiness.
For companies pursuing several markets, the dossier can also be approached as a reusable regulatory foundation with market-specific adaptations layered onto the core file.
The final scope depends on the product, target jurisdiction and maturity of the existing documentation.
Review existing regulatory, technical and administrative documentation against the expected dossier scope.
Define a clear dossier structure aligned with the relevant product and regulatory pathway.
Coordinate technical, quality, safety and product documentation required for the file.
Support dossier adaptation for the specific regulatory requirements of a target jurisdiction.
Structure supporting records so the regulatory file is clear, traceable and easier to manage.
Conduct a final structured review before the dossier enters the relevant submission process.
A structured process helps convert scattered technical information into a coherent regulatory file.
Gather existing product and regulatory documents.
Identify gaps against the intended pathway.
Organize documentation into the regulatory file.
Address market-specific documentation needs.
Complete dossier-readiness review.
Exact dossier contents depend on the product and market, but regulatory preparation generally requires several connected information domains.
Establish the product and applicant information that anchors the wider regulatory file.
The technical evidence package should be aligned with the specific product and regulatory pathway.
A structured dossier makes gaps easier to identify, responsibilities easier to assign and market adaptation easier to manage.
See what documentation exists, what is missing and what needs attention.
Replace fragmented documents with an organized regulatory information architecture.
Build a core evidence base that can support multiple market-entry workstreams where appropriate.
Move into registration with a more coherent and reviewable documentation package.
Pharmaceutical teams preparing regulatory files for product registration.
Device manufacturers organizing technical and regulatory documentation.
Companies preparing product evidence for regulated-market entry.
Teams adapting regulatory documentation across multiple target markets.
Documentation readiness is often the bridge between product development and market authorization.
International regulatory strategy, market pathway assessment and multi-market coordination.
Explore Global Regulatory AffairsPharmaceutical registration support for Bangladesh market authorization.
Explore Medicine RegistrationManufacturing-quality and GMP consulting connected with regulatory readiness.
Explore GMP ConsultingYes. Existing documentation can be assessed to identify gaps, organization issues and potential market-specific requirements.
A core documentation set may support more than one jurisdiction, but market-specific adaptation is often required.
The support model can be applied to pharmaceutical, device, diagnostic and other regulated-product projects, subject to the relevant product and market requirements.
Yes. Dossier work can be integrated with medicine registration, medical-device registration, global regulatory affairs or other connected services.
Share your product type, existing documentation, current approvals and target market with Ziva DRA so the dossier gap, structure and preparation scope can be assessed.